- Home
- PAAS vs ASND Comparison
PAAS vs ASND Comparison
Compare PAAS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAAS
- ASND
- Stock Information
- Founded
- PAAS 1994
- ASND 2006
- Country
- PAAS Canada
- ASND Denmark
- Employees
- PAAS N/A
- ASND N/A
- Industry
- PAAS
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- PAAS
- ASND Health Care
- Exchange
- PAAS Nasdaq
- ASND Nasdaq
- Market Cap
- PAAS 8.8B
- ASND 9.8B
- IPO Year
- PAAS 1995
- ASND 2015
- Fundamental
- Price
- PAAS $24.39
- ASND $162.84
- Analyst Decision
- PAAS Buy
- ASND Strong Buy
- Analyst Count
- PAAS 4
- ASND 16
- Target Price
- PAAS $30.50
- ASND $213.88
- AVG Volume (30 Days)
- PAAS 6.1M
- ASND 477.8K
- Earning Date
- PAAS 05-07-2025
- ASND 05-01-2025
- Dividend Yield
- PAAS 1.64%
- ASND N/A
- EPS Growth
- PAAS N/A
- ASND N/A
- EPS
- PAAS 0.86
- ASND N/A
- Revenue
- PAAS $2,990,700,000.00
- ASND $398,509,511.00
- Revenue This Year
- PAAS $7.42
- ASND $76.03
- Revenue Next Year
- PAAS $4.06
- ASND $74.19
- P/E Ratio
- PAAS $28.33
- ASND N/A
- Revenue Growth
- PAAS 18.34
- ASND 12.06
- 52 Week Low
- PAAS $17.86
- ASND $111.09
- 52 Week High
- PAAS $28.60
- ASND $183.00
- Technical
- Relative Strength Index (RSI)
- PAAS 50.55
- ASND 53.99
- Support Level
- PAAS $23.73
- ASND $156.56
- Resistance Level
- PAAS $24.69
- ASND $163.55
- Average True Range (ATR)
- PAAS 0.78
- ASND 6.04
- MACD
- PAAS 0.13
- ASND 0.09
- Stochastic Oscillator
- PAAS 67.54
- ASND 80.88
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.